Blog
0
Treatment With Docetaxel Reduced Risk of Death in Prostate Cancer
0

Patients with prostate cancer receiving docetaxel with the treatment of radiation and androgen deprivation therapy (ADT) or radical prostatectomy (RP) may ...

0
Supplements May Lead to Financial, Adherence Issues in Breast Cancer
0

Supplements, complementary therapies and alternative medicines can be costly for patients with breast cancer, research found. As many as a quarter of ...

0
Testosterone Recovery Improves Quality of Life After Prostate Cancer
0

Patients treated for prostate cancer tended to have better quality of life after undergoing testosterone recovery compared to those who did not. Patients ...

0
More Research Is Needed for Translocation Kidney Cancer
0

More research is needed to develop targeted therapies for patients with translocation renal cell carcinoma. While metastatic translocation renal cell ...

0
Veteran, Colon Cancer Survivor Explains Importance of PACT Act
0

Dan Nevins, a U.S. Army Reserve veteran, is a bilateral, below-knee amputee living with a traumatic brain injury as a result of his service in Iraq. But ...

0
Bone Marrow Donation
0

I had a bone marrow transplant in 2020 to combat a recurrence of acute myeloid leukemia. A year later, I was able to connect with my donor who I thought was ...

0
Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More
0

Patrick Dempsey discusses what his late mother would think of his nonprofit.Patrick Dempsey in a 2022 interview with CURE.Actor Patrick Dempsey founded The ...

0
Patients Should Actively Communicate Symptoms While Receiving Immunotherapy
0

Communicating with doctors and care teams about symptoms is essential for patients with cancer who receive immune checkpoint inhibitors, an expert told ...

0
Treatment Options for Newly Diagnosed or Recurrent Breast Cancer Subset
0

The provided transcript delves into the commonly prescribed initial hormone therapies for estrogen receptor-positive, HER2-negative breast cancer, ...

0
Lung Cancer News From 2023
0

In honor of November being Lung Cancer Awareness Month, here is a look back at some of the most impactful developments in the space from 2023.Approval of ...

0
Post-Surgical Opdivo ‘Just Makes Sense’ for Stage 2B, 2C Melanoma
0

Even after patients with stage 2B or 2C melanoma have their disease surgically removed, there is still a chance that it can come back, highlighting the need ...

0
FDA Amends Keytruda Approval for Gastric, GEJ Cancer
0

The Food and Drug Administration (FDA) revised the approval indication of Keytruda (pembrolizumab) plus Enhertu (trastuzumab), fluropyrimidine and ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart